BioCentury
ARTICLE | Clinical News

Factor VIII drugs regulatory update

August 22, 2016 7:00 AM UTC

EMA’s Pharmacovigilance Risk Assessment Committee (PRAC) began a review of approved Factor VIII drugs to treat hemophilia A to evaluate the risk of patients developing inhibitors when starting treatme...